Epr Gene Technologies Private Limited
About Epr Gene Technologies Private Limited
Data last updated:
Epr Gene Technologies Private Limited was a private limited company based in Hyderabad, Telangana, India, operated as a subsidiary of Epr Pharmaceuticals Private Limited. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 27 November 2006.
The company was registered with the Registrar of Companies (ROC), Hyderabad, under CIN U72200TG2006PTC051816.
The company had an authorised share capital of ₹1.5 Cr and a paid-up capital of ₹1.5 Cr. It was led by directors Onteddu Devi Nirmala and Markandeya Gorantla.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office was at Plot – 557 Road No.31 Jubilee Hills, Hyderabad, Telangana, India – 500033.
As per the financials filed for FY 2020, the company reported a revenue of ₹3.22 Lakh, a decline of 52% compared to the previous year. For the same year it recorded a net loss of ₹55.2 Lakh and EBITDA of -₹57.02 Lakh. Revenue has declined at a compounded annual rate (CAGR) of 24% over three years and 37% over five years.
As per MCA filings, the company had satisfied charges of ₹2.7 Cr on record.
Company details
CIN history
Epr Gene Technologies has one previous CIN (Corporate Identification Number): U72200AP2006PTC051816. The current CIN is U72200TG2006PTC051816, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U72200TG2006PTC051816 | Current |
| U72200AP2006PTC051816 | Previous |
Contact details
Epr Gene Technologies Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address is in the company report.
- Email
- Registered AddressPlot – 557 Road No.31 Jubilee Hills, Hyderabad, Telangana, India – 500033
- IndustryPharma, Pharma Contract R&D
To see the full contact details of Epr Gene Technologies Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Epr Gene Technologies is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Epr Gene Technologies Private Limited, buy the company report.
Financials of Epr Gene Technologies Private Limited
FY 2023 filings availableEpr Gene Technologies Private Limited reported revenue of ₹3.22 Lakh (down 52% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 37% over five years, including a 52% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹3.22 Lakh | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹57.02 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹55.2 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Epr Gene Technologies Private Limited, buy the company report.
Board of directors of Epr Gene Technologies Private Limited
Epr Gene Technologies has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Onteddu Devi Nirmala Also directs: NPP Bagh-Bagicha LLP | Director | 27 Nov 2006 | 19 Years 11 Months | As last reported |
| Markandeya Gorantla | Director | 10 Jul 2015 | 11 Years 3 Months | As last reported |
Auditor
Epr Gene Technologies Private Limited is audited by CH & ASSOCIATES for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| CH & ASSOCIATES | FY 2019 | 015474S |
Shareholding
The shareholding of Epr Gene Technologies Private Limited is on record for 4 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Epr Gene Technologies Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 02 Oct 2011 | 10319591 | Karvy Financial Services Limited | ₹2.7 Cr | Satisfied |
To see the full charge records of Epr Gene Technologies Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Epr Gene Technologies Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Epr Gene Technologies Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Epr Gene Technologies Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Epr Gene Technologies Private Limited has 6 board changes on record since 2006: 2 appointments and 4 cessations. The latest: Premkumar Eragam Reddy ceased to be Additional Director on 30 Sep 2019.
Frequently asked questions
Epr Gene Technologies has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Epr Gene Technologies was a private limited company based in Hyderabad, Telangana, India. The company worked in pharma contract r and d, within the pharma industry. It was incorporated on 27 November 2006 and is registered under CIN U72200TG2006PTC051816. The company has been struck off by the Registrar of Companies and is no longer operational.
Epr Gene Technologies had 2 directors:
- Onteddu Devi Nirmala - Director
- Markandeya Gorantla - Director
The CIN (Corporate Identification Number) of Epr Gene Technologies is U72200TG2006PTC051816. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Epr Gene Technologies is at Plot – 557 Road No.31 Jubilee Hills, Hyderabad, Telangana, India – 500033.
Epr Gene Technologies was incorporated on 27 November 2006. It is registered with the Registrar of Companies, Hyderabad.
The latest financial statements of Epr Gene Technologies on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from 2015 are in the company report.
Epr Gene Technologies operated in the pharma industry, in the pharma contract r and d segment. It worked in this industry before it was struck off.
Premkumar Eragam Reddy ceased to be Additional Director on 30 Sep 2019. Sirigireddy Reddy ceased to be Director on 05 Oct 2018. Swaminatha Reddy Onteddu ceased to be Director on 02 Jul 2018. Epr Gene Technologies has 6 board changes on record in total.
Epr Gene Technologies has no open charges and satisfied charges of ₹2.7 Cr as per latest MCA filings.